SCHEMBL21282159

SCHEMBL21282159

COc1ccc2nc(Nc3ccc(OC)nc3)ccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 1/20 0.49
▸ PDGFRB P09619 2/20 0.49
▸ PDGFRA P16234 2/20 0.49
▸ ACP1 P24666 1/20 0.48
▸ MEN1 O00255 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ PABPC1 P11940 1/20 0.47
▸ ALDH1A1 P00352 4/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ PIK3CA P42336 3/20 0.46
▸ MAPK8 P45983 1/20 0.46
▸ MAPK9 P45984 1/20 0.46
▸ MAPK10 P53779 1/20 0.46
▸ NCF1 P14598 1/20 0.46
▸ IGF1R P08069 1/20 0.45
▸ NQO1 P15559 1/20 0.43
▸ PIK3CD O00329 1/20 0.43
▸ PIK3CB P42338 1/20 0.43
▸ PIK3CG P48736 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21282214 0.90 PIK3CA (0.47) FYNPDGFRBPDGFRAACP1MEN1
SCHEMBL21282160 0.87 MAPT (0.44) FYNACP1MEN1KMT2APABPC1
SCHEMBL21282210 0.87 KMT2A (0.47) FYNACP1MEN1KMT2APABPC1
SCHEMBL21282171 0.86 MEN1 (0.46) FYNPDGFRBPDGFRAACP1MEN1
SCHEMBL21282158 0.86 FYN (0.50) FYNACP1MEN1KMT2APABPC1
SCHEMBL21282189 0.86 MEN1 (0.46) FYNACP1MEN1KMT2APABPC1
SCHEMBL21282164 0.84 PIK3CA (0.43) FYNPDGFRBPDGFRAACP1MEN1
SCHEMBL21282166 0.82 EGFR (0.47) PDGFRBPDGFRAMEN1KMT2AALDH1A1
SCHEMBL21282217 0.81 MEN1 (0.69) MEN1KMT2APABPC1ALDH1A1PIK3CA
SCHEMBL21282177 0.77 MEN1 (0.48) FYNPDGFRBPDGFRAACP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190256492-A1 ALPHA-SYNUCLEIN LIGANDS WASHINGTON UNIVERSITY (US) 2019-08-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256492-A1 ALPHA-SYNUCLEIN LIGANDS SNCA, PARK7, LRRK2 FYN 795/4885PDGFRB 620/4885PDGFRA 570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback